1.31 USD
↗ 0.01 (1.16%)PRE MARKET (AS OF 09:11 AM EDT)
Aldeyra Therapeutics, Inc.
ALDXNASDAQ • USD
Market: OPEN
ALDX is currently priced at $1.31. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, ALDX appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Oct 1, 2026.
Open?$1.28
High?$1.31
Low?$1.28
Prev. Close?$1.29
Volume?1.0K
Avg. Volume?872.1K
VWAP?$1.30
Rel. Volume?0.00x
Bid / Ask
Bid?$1.29 × 100
Ask?$1.37 × 100
Spread?$0.08
Midpoint?$1.33
Valuation & Ratios
Market Cap?77.8M
Shares Out?60.3M
Float?53.2M
Float %?88.2%
P/E Ratio?N/A
P/B Ratio?2.05
EPS?-$0.38
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
Address
131 HARTWELL AVENUE
LEXINGTON, MA 02421
Phone: 781-761-4904
LEXINGTON, MA 02421
Phone: 781-761-4904
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?77
Short Sent.?39
Piotroski F-Score?0/9Weak
Altman Z-Score?-10.40Distress
Confidence?44%Low
Short InterestElevated
Short % of Float?6.77%Elevated
Short Interest?3.6M
Days to Cover?4.9
Free Float53.2M
Avg Daily Volume738.2K
Settlement Date2026-09-15
Financial Health
Current Ratio?4.91Strong
Quick Ratio?4.91Strong
Cash Ratio?4.67Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.05CHEAP▾
Peers100
S&P73
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.4CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-60.9%WEAK▾
S&P3
ROA?-48.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-22043369
Enterprise Value?$32.7M
Fundamentals ratios updated end of day